Talk: How I Approach Limited Stage Hodgkin's Lymphoma

Limited stage Hodgkin lymphoma presents a unique opportunity for curative therapy with a careful balance between efficacy and long-term toxicity. This session will explore current strategies for staging, risk assessment, and integrating chemotherapy with or without radiation. Dr. Astrid Pavlovsky will share her approach to tailoring treatment based on patient characteristics and evolving clinical data, integrating the expertise of a multidisciplinary team before making final treatment decisions. Attendees will explore the potential role for new drugs in local-stage Hodgkin lymphoma and gain practical insights into optimizing outcomes while minimizing late effects in early-stage disease.